ATE241379T1 - Chemokin bindendes protein von gammaherpesvirus 68 und verfahren zu seiner verwendung - Google Patents

Chemokin bindendes protein von gammaherpesvirus 68 und verfahren zu seiner verwendung

Info

Publication number
ATE241379T1
ATE241379T1 AT00946128T AT00946128T ATE241379T1 AT E241379 T1 ATE241379 T1 AT E241379T1 AT 00946128 T AT00946128 T AT 00946128T AT 00946128 T AT00946128 T AT 00946128T AT E241379 T1 ATE241379 T1 AT E241379T1
Authority
AT
Austria
Prior art keywords
gammaherpesvirus
chemokine
binding protein
chemokine binding
protein
Prior art date
Application number
AT00946128T
Other languages
English (en)
Inventor
Stacey Efstathiou
Antonio Alcami
Christopher Marc Parry
Vincent Peter Smith
E Louro Machado De Si Monteiro
Original Assignee
Univ Cambridge Tech
Stacey Efstathiou
Alcami Antonia
Christopher Marc Parry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cambridge Tech, Stacey Efstathiou, Alcami Antonia, Christopher Marc Parry filed Critical Univ Cambridge Tech
Application granted granted Critical
Publication of ATE241379T1 publication Critical patent/ATE241379T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00946128T 1999-07-16 2000-07-17 Chemokin bindendes protein von gammaherpesvirus 68 und verfahren zu seiner verwendung ATE241379T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9916703.3A GB9916703D0 (en) 1999-07-16 1999-07-16 Viral protein binding compositions and methods
PCT/GB2000/002748 WO2001005480A2 (en) 1999-07-16 2000-07-17 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor

Publications (1)

Publication Number Publication Date
ATE241379T1 true ATE241379T1 (de) 2003-06-15

Family

ID=10857360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00946128T ATE241379T1 (de) 1999-07-16 2000-07-17 Chemokin bindendes protein von gammaherpesvirus 68 und verfahren zu seiner verwendung

Country Status (9)

Country Link
US (2) US6843991B1 (de)
EP (1) EP1200112B1 (de)
JP (1) JP2003504420A (de)
AT (1) ATE241379T1 (de)
AU (1) AU6001100A (de)
CA (1) CA2379618A1 (de)
DE (1) DE60003038T2 (de)
GB (1) GB9916703D0 (de)
WO (1) WO2001005480A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2005185T3 (da) 2006-03-22 2011-01-31 Viral Logic Systems Technology Corp Fremgangsmåde til identifikation af polypeptidtargets
GB0607774D0 (en) * 2006-04-20 2006-05-31 Renovo Group Plc Medicaments
WO2008096359A2 (en) * 2007-02-08 2008-08-14 Rappaport Family Institute For Research In The Medical Sciences Agents for the treatment of multiple sclerosis and methods of using same
US8263064B2 (en) 2007-06-04 2012-09-11 Rappaport Family Institute For Research In The Medical Sciences Method of suppressing disease severity of multiple sclerosis using chemokine CXC11
WO2010103517A1 (en) 2009-03-12 2010-09-16 Rappaport Family Institute For Research In The Medical Sciences Soluble compositions for the treatment of cxcr3-ligand associated diseases
EP3233192B1 (de) 2014-12-15 2021-04-14 Washington University Zusammensetzungen und verfahren zur gezielten freisetzung von cytokinen
AU2017213659B2 (en) 2016-02-05 2024-04-18 Washington University Compositions and methods for targeted cytokine delivery
US11351227B2 (en) 2017-04-27 2022-06-07 Washington University Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5821332A (en) 1993-11-03 1998-10-13 The Board Of Trustees Of The Leland Stanford Junior University Receptor on the surface of activated CD4+ T-cells: ACT-4
US5750653A (en) * 1995-06-07 1998-05-12 The Regents Of The University Of California Protein, FAF1, which potentiates Fas-mediated apoptosis and uses thereof
ATE196091T1 (de) 1996-05-22 2000-09-15 Univ Alberta Typ-2 chemokine-bindende proteine und verfahren zu deren verwendung
WO1998036766A1 (en) 1997-02-21 1998-08-27 Isis Innovation Limited Anti-hiv protein
WO2001021204A1 (en) 1999-09-20 2001-03-29 The John P. Robarts Research Institute Therapeutic uses of m3 polypeptide

Also Published As

Publication number Publication date
AU6001100A (en) 2001-02-05
GB9916703D0 (en) 1999-09-15
US6843991B1 (en) 2005-01-18
JP2003504420A (ja) 2003-02-04
WO2001005480A2 (en) 2001-01-25
US20050153891A1 (en) 2005-07-14
DE60003038T2 (de) 2004-04-08
WO2001005480A3 (en) 2001-09-13
CA2379618A1 (en) 2001-01-25
DE60003038D1 (de) 2003-07-03
EP1200112A2 (de) 2002-05-02
EP1200112B1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
EE200000294A (et) Tsüklilised amiini derivaadid ning meetod kemokiini seondumise sihtraku retseptoriga ja/või kemokiini toime sihtrakule inhibeerimiseks
DE69103631D1 (de) Verbessertes verfahren und apparat, um biologische substanzen in lebenden zellen einzuführen.
ATE431412T1 (de) Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen
DE60132239D1 (de) Verfahren zur vorbereitung von mikropartikeln zur verwendung in pharmazeutischen zusammensetzungen zur inhalation
ATE499153T1 (de) Verfahren zur vorhydrolyse von biomasse
DE69620832D1 (de) Zementdispersionsmittel, Verfahren zu seiner Herstellung und dieses Dispersionsmittel enthaltende Zementzusammensetzung
DE60131118D1 (de) Verfahren zur schnellen Bestimmung der Annehmbarkeit von zu sterilisierenden Ladungen
DE60336406D1 (de) Antikörper, die an zellassoziiertes ca 125/0722p binden, und verfahren zu deren anwendung
DE69739561D1 (de) Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung
NZ326555A (en) Inhibitors of interleukin-1beta converting enzyme (ICE)
ATE404587T1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
SG149000A1 (en) Gag binding proteins
DE69632742D1 (de) Verfahren zur suspendierung von einschlusskörpern
DE60034693D1 (de) Modul-aptamer und verfahren zur detektion von zielproteinen durch anwendung desselben
DE60121928D1 (de) Verfahren zur herstellung von den trans-4-n-butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)-dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
DE69917370D1 (de) Verwendung von disubstituierten Ethylen-Maleimid-Copolymeren in Kautschuk-Zusammensetzungen
ATE241379T1 (de) Chemokin bindendes protein von gammaherpesvirus 68 und verfahren zu seiner verwendung
DE60009704D1 (de) Zusammensetzung zur vorbeugung von muskulärer erschöpfung und zur anpassung von skelettmuskel an intensive körperliche anstrengung
DE50106993D1 (de) Neue 7-azaindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung
EE200000151A (et) Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
DK0821693T3 (da) Nye DNA-sekvenser fra human cytomegalovirus (HCMV)
ATE316968T1 (de) P-thienylbenzyl-amide als agonisten von angiotensin-(1-7)-rezeptoren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE69811220D1 (de) Zusammensetzungen zum konservieren von lebenden biologischen materialien und verfahren zu ihrer verwendung
DE60035942D1 (de) Verfahren zur Zuführung von Umschlägen an eine Kuvertiereinrichtung
DE69928656D1 (de) Gentechnisch hergestellte hefestämme und deren mutanten zur fermentierung von lignocellulosehydrolysate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties